Reducing greenhouse gas emissions is a major challenge. Inhalers have a significant impact on the environment due to their greenhouse gas emissions. However, inhalation therapy plays a fundamental and essential role in the treatment of patients with cystic fibrosis. They therefore represent a target group with high potential for the implementation of strategic measures to reduce the environmental impact of devices.
Autoren
- Jens Dehn
Publikation
- InFo PNEUMOLOGIE & ALLERGOLOGIE
Related Topics
You May Also Like
- Atrial fibrillation
Anticoagulation after catheter ablation – for how long?
- Wound treatment and dermal defect coverage
Fish skin matrix for the treatment of complex ulcers
- Well-being of the medical profession in primary care
Findings of a nationwide survey in Switzerland
- Severe asthma and CRSwNP
Multidisciplinary collaboration between pneumology, allergology and ENT
- Myelofibrosis
New findings on the role of inflammation in pathogenesis
- Incretin mimetics for obesity and prediabetes
Liraglutide, semaglutide and tirzepatide: considerable evidence base
- Treatment of infected wounds and wounds at risk of infection
Focus on an interdisciplinary perspective
- Chronic and hard-to-heal wounds